Don't miss

Replay


LATEST SHOWS

EYE ON AFRICA

Kenya’s opposition files a petition against presidential vote

Read more

MEDIAWATCH

'Siempre vida Barcelona'

Read more

THE DEBATE

Spain attacks - Can Europe prepare for vehicle-ramming terror attacks?

Read more

EYE ON AFRICA

Measures in place to prevent Grace Mugabe leaving South Africa

Read more

IN THE PAPERS

Terror in Barcelona

Read more

BUSINESS DAILY

Terror attack, Trump turmoil rattle stock markets

Read more

FRENCH CONNECTIONS

Malbouffe: understanding junk food à la française

Read more

IN THE PAPERS

Lebanon repeals 'rape law', but activists say more is needed to protect women

Read more

BUSINESS DAILY

US business leaders abandon Trump after Charlottesville

Read more

Sports

Marseille-PSG showdown goes ahead despite swine flu worries

Text by News Wires

Latest update : 2009-10-25

Football officials have decided not to postpone Sunday's league match between Marseille and Paris Saint Germain despite concerns about players with flu symptoms.

AFP - The highly-charged French league match between Marseille and Paris Saint Germain will go ahead despite two of the latter club's players undergoing tests for swine flu, the French Professional League (LFP) announced on Saturday.
   
Both former France international winger Ludovic Giuly and defender Mamadou Sakho have been unwell with flu symptoms for the last two days and they were tested on Friday afternoon.
   
However, the LFP said in a statement issued on Saturday that Sunday's match would still go ahead.
   
"The competitions commission after taking advice from the medical commission of the French Football Federation (FFF) that the match between Marseille and PSG will go ahead as planned," read the statement.
   
There have been isolated cases of swine flu among professional footballers in France but as yet no top level game has been called off as a precautionary measure.
   

Date created : 2009-10-24

  • INFLUENZA A (H1N1)

    France starts swine flu vaccination campaign

    Read more

COMMENT(S)